BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10440778)

  • 1. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats.
    Patlas N; Golomb G; Yaffe P; Pinto T; Breuer E; Ornoy A
    Teratology; 1999 Aug; 60(2):68-73. PubMed ID: 10440778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salicylamide on skeletal glycosaminoglycan sulfation and calcification in fetal rat limbs.
    Halstead PK; Roe DA
    Drug Nutr Interact; 1981; 1(1):75-86. PubMed ID: 6821388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring.
    Migliaccio S; Newbold RR; Bullock BC; Jefferson WJ; Sutton FG; McLachlan JA; Korach KS
    Endocrinology; 1996 May; 137(5):2118-25. PubMed ID: 8612556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the bisphosphonate, alendronate, on parturition in the rat.
    Minsker DH; Manson JM; Peter CP
    Toxicol Appl Pharmacol; 1993 Aug; 121(2):217-23. PubMed ID: 8346538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of concurrent administration of alendronate sodium and retinol on development of changes in histomorphometric parameters of bones induced by ovariectomy in rats.
    Pytlik M; Kaczmarczyk-Sedlak I; Sliwiński L; Janiec W; Rymkiewicz I
    Pol J Pharmacol; 2004; 56(5):571-9. PubMed ID: 15591645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplacental effects of thyrocalcitonin on intestinal calcium-binding protein, alkaline phosphatase activity and ossification of long bones in rat fetuses.
    Peshin J; Ornoy A; Menczel J
    Isr J Med Sci; 1976 Mar; 12(3):248-56. PubMed ID: 931722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
    Allen MR; Iwata K; Phipps R; Burr DB
    Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae.
    Balena R; Markatos A; Seedor JG; Gentile M; Stark C; Peter CP; Rodan GA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):277-83. PubMed ID: 8558443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enoxaparin on histomorphometric parameters of bones in rats.
    Folwarczna J; Janiec W; Gawor M; Pytlik M; Kaczmarczyk-Sedlak I; Nowińska B
    Pol J Pharmacol; 2004; 56(4):451-7. PubMed ID: 15520500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alendronate and pamidronate on cultured rat metatarsal bones: failure to prevent dexamethasone-induced growth retardation.
    Heino TJ; Chagin AS; Takigawa M; Sävendahl L
    Bone; 2008 Apr; 42(4):702-9. PubMed ID: 18276203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of weightlessness on the skeletal development of the rat fetus].
    Denisova LA
    Kosm Biol Aviakosm Med; 1986; 20(4):60-3. PubMed ID: 3762055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 2002 Jan; 73(1):24-30. PubMed ID: 11928907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long bone development in extrinsic fetal akinesia: an experimental study in rat fetuses subjected to oligohydramnios.
    Palacios J; Rodríguez JI; Ruiz A; Sanchez M; Alvarez I; DeMiguel E
    Teratology; 1992 Jul; 46(1):79-84. PubMed ID: 1641814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eicosapentaenoic acid on bone changes due to methylprednisolone in rats.
    Shomali T; Rezaian M; Rassouli A; Asadi F
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):46-50. PubMed ID: 19302435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
    Camacho NP; Carroll P; Raggio CL
    Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anabolic effects of bisphosphonates on peri-implant bone stock.
    von Knoch F; Eckhardt C; Alabre CI; Schneider E; Rubash HE; Shanbhag AS
    Biomaterials; 2007 Aug; 28(24):3549-59. PubMed ID: 17498799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis.
    Myers SL; Brandt KD; Burr DB; O'Connor BL; Albrecht M
    J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties.
    Day JS; Ding M; Bednarz P; van der Linden JC; Mashiba T; Hirano T; Johnston CC; Burr DB; Hvid I; Sumner DR; Weinans H
    J Orthop Res; 2004 May; 22(3):465-71. PubMed ID: 15099622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological changes in long bone development in fetal akinesia deformation sequence: an experimental study in curarized rat fetuses.
    Rodríguez JI; Palacios J; Ruiz A; Sanchez M; Alvarez I; Demiguel E
    Teratology; 1992 Feb; 45(2):213-21. PubMed ID: 1615431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal toxicity caused by excessive maternal dietary calcium.
    Liebgott B; Srebrolow G
    J Can Dent Assoc; 1989 Feb; 55(2):129-33. PubMed ID: 2645029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.